SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $512,000 | -8.6% | 1,966,100 | -15.7% | 0.00% | 0.0% |
| Q1 2016 | $560,000 | -36.4% | 2,332,995 | -6.8% | 0.00% | -50.0% |
| Q4 2015 | $881,000 | -30.8% | 2,504,200 | +281.3% | 0.00% | -33.3% |
| Q1 2015 | $1,274,000 | -24.8% | 656,700 | +2.7% | 0.00% | -25.0% |
| Q4 2014 | $1,695,000 | +49.2% | 639,581 | +69.5% | 0.00% | +33.3% |
| Q3 2014 | $1,136,000 | +1.3% | 377,275 | +76.3% | 0.00% | 0.0% |
| Q4 2013 | $1,121,000 | – | 214,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |